Search research articles
Contact Us
Filters
Showing results (461-470 of 512) with videos related to
Page
of 52
Sort By:
British Journal of Haematology
|
September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma
John Kuruvilla, Christopher Rushton, Diego Villa, et al.
Blood
|
July 3, 2016
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas
David Vallois, Maria Pamela D Dobay, Ryan D Morin, et al.
Cell Reports
|
October 13, 2021
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Blood
|
May 12, 2016
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
Sarit E Assouline, Torsten Holm Nielsen, Stephen Yu, et al.
Cell Reports
|
February 19, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Blood
|
March 8, 2021
Characterization of DLBCL with a PMBL gene expression signature
Gerben Duns, Elena Viganò, Daisuke Ennishi, et al.
Blood
|
May 8, 2014
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis
Tobias Berg, Silvia Thoene, Damian Yap, et al.
Blood
|
October 27, 2022
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
Waleed Alduaij, Brett Collinge, Susana Ben-Neriah, et al.
Blood Advances
|
October 24, 2018
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphology
Lauren C Chong, Susana Ben-Neriah, Graham W Slack, et al.
Blood Advances
|
April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma
Laura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 512) with videos related to
Sort By:
Page
of 52
British Journal of Haematology
|
September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma
John Kuruvilla, Christopher Rushton, Diego Villa, et al.
Blood
|
July 3, 2016
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas
David Vallois, Maria Pamela D Dobay, Ryan D Morin, et al.
Cell Reports
|
October 13, 2021
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Blood
|
May 12, 2016
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
Sarit E Assouline, Torsten Holm Nielsen, Stephen Yu, et al.
Cell Reports
|
February 19, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Blood
|
March 8, 2021
Characterization of DLBCL with a PMBL gene expression signature
Gerben Duns, Elena Viganò, Daisuke Ennishi, et al.
Blood
|
May 8, 2014
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis
Tobias Berg, Silvia Thoene, Damian Yap, et al.
Blood
|
October 27, 2022
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
Waleed Alduaij, Brett Collinge, Susana Ben-Neriah, et al.
Blood Advances
|
October 24, 2018
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphology
Lauren C Chong, Susana Ben-Neriah, Graham W Slack, et al.
Blood Advances
|
April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma
Laura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Page
of 52